http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6f7824f93d8cac2aa1e751c50dbe7ae9
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Sabirsh |
| name | Alan Sabirsh |
| given-name | Alan |
| organization-name | Department of Medical Biochemistry and BiophysicsDivisions of Chemistry 2Divisions of Chemistry 1Karolinska InstitutetStockholmSweden AstraZeneca Cardiovascular and Metabolic Disease iMed, Molndal, Sweden; and Cardiovascular & Metabolic Diseases, AstraZeneca, Gothenburg, Sweden; Cardiovascular & Metabolic Disease Innovative Medicines AstraZeneca R&D Gothenburg Mölndal Sweden Section of Molecular Neurobiology, Wallenberg Neuroscience Center, University of Lund, S-22362 Lund, Sweden; and Institute of Human Virology, Medical Biotechnology Center, University of Maryland Biotechnology Institute, Baltimore, MD 21201 Advanced Drug Delivery Pharmaceutical Sciences R&D AstraZeneca 1 Pepparedsleden Mölndal 431 50 Sweden Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 77 Stockholm, Sweden, Adelard Institute, London NW7 3NY, England, Magdalen College, Oxford OX1 4AU, England, and Drug Target Discovery, Lund University, BMC A12, 22184 Lund, Sweden Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Discovery Unit, AstraZeneca Pepparedsleden 1 Mölndal 431 83 Sweden Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, Gothenburg SE-431 83, Sweden Department of Medical Biochemistry and Biophysics, Karolinska Institute , Stockholm, Sweden |
Incoming Links
Total number of triples: 43.